Bank Sinarmas Tbk vs Merck Tbk. — how do they compare? Bank Sinarmas Tbk trades at Rp695 (market cap 13.56T, 16.1K 24h volume), while Merck Tbk. trades at Rp3,800 (market cap 1.68T, 33.3K 24h volume). The key difference: Bank Sinarmas Tbk is far larger — about 8.1× Merck Tbk.'s market cap, and Merck Tbk. is more actively traded (33.3K versus 16.1K). Which is the better fit depends on your goals.
| BSIM | MERK | |
|---|---|---|
Market Cap | 13.56T | 1.68T |
Volume | 16.1K | 33.3K |
Lot | 161 | 333 |
Turnover | 11.29M | 126.46M |
Average Price | 700.99 | 3,797.72 |
Value | 11.29M | 126.46M |
Indicative Equilibrium Price | 700 | 3,800 |
Indicative Equilibrium Volume | 1 | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Sinarmas (the company) was established under its original name of PT Bank Shinta Indonesia base on notarial deed No.52 of Mr Buniarti Tjandra, S.H, dated on 18 Aug, 1989. The Company’s articles of association has been amended several times, most recently by notarial deed No.31 of Sutjipto, S.H., dated Apr 6 2010, concerning among others, change in par value, the name of the company, and public offering.
Read more on BSIM →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →